By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

SenzaGen AB markets, sells and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its own laboratory and through licensed Contract Research Organization (CROs) in Sweden. It offers animal-free testing of chemical compounds in cosmetics, pharmaceuticals, food products and dyes.

Contact Information

Website: www.senzagen.com
Main Phone: +46 462756200
Address: Scheelevagen 2
Address 2: Medicon Village, Building 401
City / Town: Lund
Country: SE
Postal Code: 223 81

Issuer Information

Exchange: OTO
Employees: 17

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A